Verastem, Inc. (VSTM)
7.425
+0.20
(+2.84%)
USD |
NASDAQ |
Sep 01, 11:12
Verastem Cash and Short Term Investments (Quarterly) : 136.35M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 136.35M |
| March 31, 2026 | 181.68M |
| December 31, 2025 | 204.99M |
| September 30, 2025 | 137.71M |
| June 30, 2025 | 164.32M |
| March 31, 2025 | 117.57M |
| December 31, 2024 | 88.82M |
| September 30, 2024 | 113.42M |
| June 30, 2024 | 83.37M |
| March 31, 2024 | 111.16M |
| December 31, 2023 | 138.06M |
| September 30, 2023 | 167.20M |
| June 30, 2023 | 184.08M |
| March 31, 2023 | 111.20M |
| December 31, 2022 | 87.89M |
| September 30, 2022 | 103.98M |
| June 30, 2022 | 94.31M |
| March 31, 2022 | 106.28M |
| December 31, 2021 | 100.26M |
| September 30, 2021 | 103.42M |
| June 30, 2021 | 108.14M |
| March 31, 2021 | 121.10M |
| December 31, 2020 | 141.23M |
| September 30, 2020 | 179.84M |
| June 30, 2020 | 130.22M |
| Date | Value |
|---|---|
| March 31, 2020 | 135.06M |
| December 31, 2019 | 75.51M |
| September 30, 2019 | 160.77M |
| June 30, 2019 | 187.79M |
| March 31, 2019 | 212.20M |
| December 31, 2018 | 250.39M |
| September 30, 2018 | 145.80M |
| June 30, 2018 | 168.69M |
| March 31, 2018 | 64.22M |
| December 31, 2017 | 86.67M |
| September 30, 2017 | 60.26M |
| June 30, 2017 | 57.92M |
| March 31, 2017 | 72.57M |
| December 31, 2016 | 80.90M |
| September 30, 2016 | 86.88M |
| June 30, 2016 | 92.87M |
| March 31, 2016 | 99.54M |
| December 31, 2015 | 110.26M |
| September 30, 2015 | 120.47M |
| June 30, 2015 | 132.09M |
| March 31, 2015 | 132.07M |
| December 31, 2014 | 92.68M |
| September 30, 2014 | 93.37M |
| June 30, 2014 | 98.60M |
| March 31, 2014 | 105.64M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 956.47M |
| Dianthus Therapeutics, Inc. | 886.81M |
| Alnylam Pharmaceuticals, Inc. | 3.308B |
| Anika Therapeutics, Inc. | 38.41M |
| Savara, Inc. | 173.03M |